List of Tables
Table 1. Global Targeted Drug VEGFR2 Inhibitors for NSCLC Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Ramucirumab
Table 3. Key Players of Others
Table 4. Global Targeted Drug VEGFR2 Inhibitors for NSCLC Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Targeted Drug VEGFR2 Inhibitors for NSCLC Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Targeted Drug VEGFR2 Inhibitors for NSCLC Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Targeted Drug VEGFR2 Inhibitors for NSCLC Market Share by Region (2020-2025)
Table 8. Global Targeted Drug VEGFR2 Inhibitors for NSCLC Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Targeted Drug VEGFR2 Inhibitors for NSCLC Market Share by Region (2026-2031)
Table 10. Targeted Drug VEGFR2 Inhibitors for NSCLC Market Trends
Table 11. Targeted Drug VEGFR2 Inhibitors for NSCLC Market Drivers
Table 12. Targeted Drug VEGFR2 Inhibitors for NSCLC Market Challenges
Table 13. Targeted Drug VEGFR2 Inhibitors for NSCLC Market Restraints
Table 14. Global Targeted Drug VEGFR2 Inhibitors for NSCLC Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Targeted Drug VEGFR2 Inhibitors for NSCLC Market Share by Players (2020-2025)
Table 16. Global Top Targeted Drug VEGFR2 Inhibitors for NSCLC Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted Drug VEGFR2 Inhibitors for NSCLC as of 2024)
Table 17. Ranking of Global Top Targeted Drug VEGFR2 Inhibitors for NSCLC Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Targeted Drug VEGFR2 Inhibitors for NSCLC Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Targeted Drug VEGFR2 Inhibitors for NSCLC, Headquarters and Area Served
Table 20. Global Key Players of Targeted Drug VEGFR2 Inhibitors for NSCLC, Product and Application
Table 21. Global Key Players of Targeted Drug VEGFR2 Inhibitors for NSCLC, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Targeted Drug VEGFR2 Inhibitors for NSCLC Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Targeted Drug VEGFR2 Inhibitors for NSCLC Revenue Market Share by Type (2020-2025)
Table 25. Global Targeted Drug VEGFR2 Inhibitors for NSCLC Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Targeted Drug VEGFR2 Inhibitors for NSCLC Revenue Market Share by Type (2026-2031)
Table 27. Global Targeted Drug VEGFR2 Inhibitors for NSCLC Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Targeted Drug VEGFR2 Inhibitors for NSCLC Revenue Market Share by Application (2020-2025)
Table 29. Global Targeted Drug VEGFR2 Inhibitors for NSCLC Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Targeted Drug VEGFR2 Inhibitors for NSCLC Revenue Market Share by Application (2026-2031)
Table 31. North America Targeted Drug VEGFR2 Inhibitors for NSCLC Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Targeted Drug VEGFR2 Inhibitors for NSCLC Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Targeted Drug VEGFR2 Inhibitors for NSCLC Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Targeted Drug VEGFR2 Inhibitors for NSCLC Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Targeted Drug VEGFR2 Inhibitors for NSCLC Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Targeted Drug VEGFR2 Inhibitors for NSCLC Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Targeted Drug VEGFR2 Inhibitors for NSCLC Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Targeted Drug VEGFR2 Inhibitors for NSCLC Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Targeted Drug VEGFR2 Inhibitors for NSCLC Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Targeted Drug VEGFR2 Inhibitors for NSCLC Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Targeted Drug VEGFR2 Inhibitors for NSCLC Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Targeted Drug VEGFR2 Inhibitors for NSCLC Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Targeted Drug VEGFR2 Inhibitors for NSCLC Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Targeted Drug VEGFR2 Inhibitors for NSCLC Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Targeted Drug VEGFR2 Inhibitors for NSCLC Market Size by Country (2026-2031) & (US$ Million)
Table 46. ImClone Systems (Eli Lilly) Company Details
Table 47. ImClone Systems (Eli Lilly) Business Overview
Table 48. ImClone Systems (Eli Lilly) Targeted Drug VEGFR2 Inhibitors for NSCLC Product
Table 49. ImClone Systems (Eli Lilly) Revenue in Targeted Drug VEGFR2 Inhibitors for NSCLC Business (2020-2025) & (US$ Million)
Table 50. ImClone Systems (Eli Lilly) Recent Development
Table 51. Research Programs/Design for This Report
Table 52. Key Data Information from Secondary Sources
Table 53. Key Data Information from Primary Sources
Table 54. Authors List of This Report
List of Figures
Figure 1. Targeted Drug VEGFR2 Inhibitors for NSCLC Picture
Figure 2. Global Targeted Drug VEGFR2 Inhibitors for NSCLC Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Targeted Drug VEGFR2 Inhibitors for NSCLC Market Share by Type: 2024 VS 2031
Figure 4. Ramucirumab Features
Figure 5. Others Features
Figure 6. Global Targeted Drug VEGFR2 Inhibitors for NSCLC Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Targeted Drug VEGFR2 Inhibitors for NSCLC Market Share by Application: 2024 VS 2031
Figure 8. Squamous Cell Carcinoma of NSCLC Case Studies
Figure 9. Adenocarcinoma of NSCLC Case Studies
Figure 10. Large Cell Carcinoma of NSCLC Case Studies
Figure 11. Targeted Drug VEGFR2 Inhibitors for NSCLC Report Years Considered
Figure 12. Global Targeted Drug VEGFR2 Inhibitors for NSCLC Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Targeted Drug VEGFR2 Inhibitors for NSCLC Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Targeted Drug VEGFR2 Inhibitors for NSCLC Market Share by Region: 2024 VS 2031
Figure 15. Global Targeted Drug VEGFR2 Inhibitors for NSCLC Market Share by Players in 2024
Figure 16. Global Top Targeted Drug VEGFR2 Inhibitors for NSCLC Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted Drug VEGFR2 Inhibitors for NSCLC as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Targeted Drug VEGFR2 Inhibitors for NSCLC Revenue in 2024
Figure 18. North America Targeted Drug VEGFR2 Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Targeted Drug VEGFR2 Inhibitors for NSCLC Market Share by Country (2020-2031)
Figure 20. United States Targeted Drug VEGFR2 Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Targeted Drug VEGFR2 Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Targeted Drug VEGFR2 Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Targeted Drug VEGFR2 Inhibitors for NSCLC Market Share by Country (2020-2031)
Figure 24. Germany Targeted Drug VEGFR2 Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Targeted Drug VEGFR2 Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Targeted Drug VEGFR2 Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Targeted Drug VEGFR2 Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Targeted Drug VEGFR2 Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Targeted Drug VEGFR2 Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Targeted Drug VEGFR2 Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Targeted Drug VEGFR2 Inhibitors for NSCLC Market Share by Region (2020-2031)
Figure 32. China Targeted Drug VEGFR2 Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Targeted Drug VEGFR2 Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Targeted Drug VEGFR2 Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Targeted Drug VEGFR2 Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Targeted Drug VEGFR2 Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Targeted Drug VEGFR2 Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Targeted Drug VEGFR2 Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Targeted Drug VEGFR2 Inhibitors for NSCLC Market Share by Country (2020-2031)
Figure 40. Mexico Targeted Drug VEGFR2 Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Targeted Drug VEGFR2 Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Targeted Drug VEGFR2 Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Targeted Drug VEGFR2 Inhibitors for NSCLC Market Share by Country (2020-2031)
Figure 44. Turkey Targeted Drug VEGFR2 Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Targeted Drug VEGFR2 Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Targeted Drug VEGFR2 Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. ImClone Systems (Eli Lilly) Revenue Growth Rate in Targeted Drug VEGFR2 Inhibitors for NSCLC Business (2020-2025)
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed
